SeaStar Medical Holding Corporation ICU
3.42
(0.02)
(0.58%)
as of 25 Sep
- Market cap
- $15.2M
- P/E
- 0.0×
Follow ICU
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(290.37%) | (295.15%) | (302.01%) | (356.87%) | |
| (135.86%) | (129.15%) | (126.18%) | (160.02%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(126.43%) | (123.50%) | (174.57%) | (351.66%) | |
Average Days of Receivables |
91.56 | 70.10 | 45.50 | 44.32 | |
Free Cash Flow per Share |
(5.38) | (6.56) | (3.50) | (3.35) | |
Free Cash Flow |
(14.20) | (13.60) | (13.71) | (13.69) | |
Piotroski F-Score |
0.00 | 0.00 | 0.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
(56.28%) | (60.72%) | (82.25%) | (121.66%) | |
Accounts Receivable Turnover |
6.10 | 7.07 | 9.94 | 8.06 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.05 | 0.06 | |
Inventory Turnover |
— | — | 1.96 | 1.64 | |
Average Days of Payables |
0.00 | 0.00 | 2,650.86 | 2,172.62 | |
Days of Inventory on Hand |
0.00 | 0.00 | 210.15 | 223.06 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
914.42% | 609.24% | 517.48% | 520.37% | |
Selling, General and Administrative Expense of Revenue |
761.41% | 473.10% | 408.22% | 389.03% | |
Share Based Compensation of Revenue |
120.77% | 74.72% | 58.91% | 20.55% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.04 | 1.12 | 1.15 | 1.00 | |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
0.33 | 0.60 | 0.37 | 0.42 | |
Operating CF per Share |
(5.38) | (6.56) | (3.50) | (3.35) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(1,551.08%) | (984.60%) | (828.62%) | (795.50%) |
Columns are period end dates